Kiniksa Pharmaceuticals Ltd (KNSA) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Kiniksa Pharmaceuticals Ltd ranks 7 of 11 in its cohort on the Closelook composite (56/100) — the cohort is led by DexCom Inc at 66/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
KNSA Kiniksa Pharmaceuticals Ltd 56 92 58 19 ok 6.9%
ROVI.MC Laboratorios Farmaceuticos ROVI 60 20 76 51 info 32.3%
LNTH Lantheus Holdings Inc 60 69 75 58 info 10.1%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 54 89 57 42 ok 2.9%
BHC.TO Bausch Health Companies Inc 54 50 70 83 info 28.5%
ALKS Alkermes Plc 53 66 52 22 info 22.1%
ALM.MC Almirall S.A. 52 23 44 66 warn 24.3%
DXCM DexCom Inc 66 86 80 35 bull 5%
ARGX argenx NV ADR 64 79 74 27 ok 7.7%
ONC BeiGene, Ltd. 63 75 63 32 ok 8.9%
MEDP Medpace Holdings Inc 63 86 74 29 ok 9.7%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are Kiniksa Pharmaceuticals Ltd's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Lantheus Holdings Inc (LNTH), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), Bausch Health Companies Inc (BHC.TO), Alkermes Plc (ALKS), Almirall S.A. (ALM.MC), DexCom Inc (DXCM), argenx NV ADR (ARGX) and others.

How does KNSA score against its peers?

Kiniksa Pharmaceuticals Ltd's composite reads 56/100, ranking 7 of 11 in its cohort as of 2026-09-18; the cohort's highest composite is DexCom Inc at 66/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.